Looking further in energy metabolism, it has been shown that a mutation in IDH1/2 genes inhibits isocitrate dehydrogenase activity and correlates with decreased NAA and NAAG levels in gliomas [45]. This evidence concerns the gene IDH3A and central nervous system cancer.